ASLAN PHARMACEUTICALS LTD's ticker is ASLN and the CUSIP is 04522R101. A total of 38 filers reported holding ASLAN PHARMACEUTICALS LTD in Q3 2021. The put-call ratio across all filers is 42.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14 | -99.9% | 39,841 | 0.0% | 0.00% | – |
| Q3 2022 | $23,000 | +21.1% | 39,841 | 0.0% | 0.00% | – |
| Q2 2022 | $19,000 | -45.7% | 39,841 | 0.0% | 0.00% | – |
| Q1 2022 | $35,000 | -20.5% | 39,841 | 0.0% | 0.00% | – |
| Q4 2021 | $44,000 | -86.4% | 39,841 | -78.1% | 0.00% | – |
| Q3 2021 | $323,000 | -27.4% | 181,659 | +34.5% | 0.00% | – |
| Q2 2021 | $445,000 | +535.7% | 135,020 | +541.9% | 0.00% | – |
| Q1 2021 | $70,000 | – | 21,036 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 568,182 | $1,068,181 | 0.12% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |